Corrigendum to "Prognostic Impact of Interleukin-1 Receptor Antagonist in Patients with documented Coronary Artery Disease" [Int. J. Cardiol. 257 (2018) 24-29]
Int J Cardiol. 2018 Jun 15:261:239.
doi: 10.1016/j.ijcard.2018.03.012.
Epub 2018 Mar 21.
1 Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany. Electronic address: n.schofer@uke.de.
2 Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.
3 Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany; German Center of Cardiovascular Research (DZHK), Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.
4 Department of Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany.
5 Department of Medicine II, GPR Klinikum Ruesselsheim, Ruesselsheim, Germany.
6 Department of Internal Medicine, Federal Armed Forces Hospital Koblenz, Koblenz, Germany.
7 Department of Cardiology, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany.